X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (4778) 4778
Book Review (808) 808
Publication (331) 331
Book / eBook (20) 20
Book Chapter (11) 11
Conference Proceeding (5) 5
Dissertation (4) 4
Magazine Article (1) 1
Newspaper Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (4498) 4498
humans (4366) 4366
female (3424) 3424
middle aged (2695) 2695
male (2393) 2393
oncology (2298) 2298
aged (2227) 2227
adult (2013) 2013
surgery (2011) 2011
cancer (1775) 1775
peritoneal neoplasms - secondary (1523) 1523
prognosis (1439) 1439
chemotherapy (1390) 1390
peritoneal neoplasms - mortality (1252) 1252
survival rate (1143) 1143
retrospective studies (1069) 1069
combined modality therapy (1022) 1022
treatment outcome (975) 975
peritoneal neoplasms - therapy (972) 972
neoplasm staging (956) 956
cytoreductive surgery (954) 954
peritoneal neoplasms - surgery (912) 912
peritoneal neoplasms - drug therapy (884) 884
aged, 80 and over (829) 829
survival (823) 823
peritoneal carcinomatosis (810) 810
peritoneal neoplasms - pathology (794) 794
medicine & public health (788) 788
follow-up studies (728) 728
antineoplastic combined chemotherapy protocols - therapeutic use (707) 707
ovarian cancer (702) 702
metastasis (688) 688
hyperthermia, induced (679) 679
analysis (661) 661
carcinoma (634) 634
stomach neoplasms - pathology (604) 604
survival analysis (597) 597
mortality (595) 595
ovarian neoplasms - pathology (592) 592
care and treatment (546) 546
health aspects (504) 504
hyperthermic intraperitoneal chemotherapy (494) 494
surgical oncology (490) 490
colorectal cancer (489) 489
colorectal neoplasms - pathology (485) 485
carcinomatosis (468) 468
abridged index medicus (467) 467
management (456) 456
animals (447) 447
chemotherapy, adjuvant (440) 440
ovarian neoplasms - mortality (434) 434
colorectal-cancer (433) 433
prospective studies (432) 432
stomach neoplasms - mortality (425) 425
obstetrics & gynecology (421) 421
risk factors (420) 420
tumors (413) 413
disease-free survival (411) 411
research (411) 411
intraperitoneal chemotherapy (399) 399
lymphatic metastasis (394) 394
ovarian neoplasms - drug therapy (387) 387
morbidity (377) 377
gastroenterology & hepatology (375) 375
hematology, oncology and palliative medicine (373) 373
gastric cancer (367) 367
liver neoplasms - secondary (366) 366
antineoplastic agents - administration & dosage (361) 361
hipec (360) 360
infusions, parenteral (360) 360
young adult (355) 355
stomach cancer (348) 348
adolescent (321) 321
stomach neoplasms - surgery (319) 319
recurrence (318) 318
time factors (317) 317
cisplatin (312) 312
antineoplastic agents - therapeutic use (311) 311
mesothelioma (309) 309
pseudomyxoma peritonei (297) 297
chemotherapy, cancer, regional perfusion (291) 291
peritoneum (282) 282
ovarian neoplasms - surgery (276) 276
kaplan-meier estimate (274) 274
adenocarcinoma (272) 272
neoplasm invasiveness (263) 263
multivariate analysis (252) 252
peritoneal neoplasms - diagnosis (252) 252
cisplatin - administration & dosage (251) 251
mice (251) 251
diagnosis (250) 250
systemic chemotherapy (246) 246
origin (244) 244
cytoreduction surgical procedures (243) 243
adenocarcinoma - mortality (241) 241
laparoscopy (241) 241
hyperthermia, induced - methods (238) 238
pathology (236) 236
therapy (235) 235
colorectal neoplasms - mortality (230) 230
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (10) 10
Collection Dvlpm't (Acquisitions) - Closed Orders (1) 1
Dentistry (Harry R Abbott) - Withdrawn (1) 1
Humber River Regional Hospital - Church Stacks (1) 1
Lakeridge Health Sciences - Oshawa (1) 1
Scarborough Hospital - General (1) 1
St. Michael's Hospital - Stacks (1) 1
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (1) 1
UTL at Downsview - May be requested (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (4549) 4549
German (61) 61
Japanese (61) 61
French (50) 50
Italian (41) 41
Spanish (16) 16
Chinese (10) 10
Russian (8) 8
Polish (4) 4
Danish (3) 3
Romanian (3) 3
Swedish (3) 3
Finnish (2) 2
Hungarian (2) 2
Arabic (1) 1
Bulgarian (1) 1
Czech (1) 1
Dutch (1) 1
Hebrew (1) 1
Korean (1) 1
Serbian (1) 1
Ukrainian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of Clinical Oncology, ISSN 0732-183X, 12/2015, Volume 33, Issue 34, pp. 4015 - 4022
Journal Article
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 2014, Volume 32, Issue 15, pp. 1547 - 1553
Journal Article
Journal Article
Journal Article
Clinical Cancer Research, ISSN 1078-0432, 2014, Volume 20, Issue 3, pp. 764 - 775
Journal Article
Annals of Surgical Oncology, ISSN 1068-9265, 12/2012, Volume 19, Issue 13, pp. 4059 - 4067
To analyze the impact of radical cytoreductive surgery—as part of primary tumor debulking—on the amount of residual tumor and survival in patients with... 
Oncology | Medicine & Public Health | Surgical Oncology | Surgery | SURGERY | PROGNOSTIC-FACTOR | GYNECOLOGIC-ONCOLOGY-GROUP | ONCOLOGY | RESECTION | CARCINOMA | Prognosis | Follow-Up Studies | Neoplasm, Residual - surgery | Endometrial Neoplasms - mortality | Adenocarcinoma, Clear Cell - mortality | Humans | Middle Aged | Neoplasm Recurrence, Local - drug therapy | Gynecologic Surgical Procedures | Ovarian Neoplasms - mortality | Neoplasm Recurrence, Local - mortality | Cystadenocarcinoma, Serous - drug therapy | Neoplasm Recurrence, Local - surgery | Peritoneal Neoplasms - drug therapy | Neoplasm Grading | Adenocarcinoma, Mucinous - surgery | Adult | Female | Neoadjuvant Therapy | Chemotherapy, Adjuvant | Neoplasm, Residual - mortality | Adenocarcinoma, Mucinous - drug therapy | Ovarian Neoplasms - drug therapy | Adenocarcinoma, Clear Cell - surgery | Peritoneal Neoplasms - surgery | Survival Rate | Combined Modality Therapy | Lymphatic Metastasis | Peritoneal Neoplasms - mortality | Cystadenocarcinoma, Serous - surgery | Adenocarcinoma, Mucinous - mortality | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Endometrial Neoplasms - surgery | Neoplasm, Residual - drug therapy | Cystadenocarcinoma, Serous - mortality | Endometrial Neoplasms - drug therapy | Aged | Neoplasm Staging | Adenocarcinoma, Clear Cell - drug therapy | Ovarian Neoplasms - surgery | Chemotherapy | Analysis | Ovarian cancer | Cancer | Index Medicus
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2014, Volume 15, Issue 13, pp. 1442 - 1450
Summary Background Poor prognosis germ-cell tumours are only cured in about half of patients. We aimed to assess whether treatment intensification based on an... 
Hematology, Oncology and Palliative Medicine | SURVIVAL | 1ST CYCLE | ETOPOSIDE | THERAPY | SOUTHWEST-ONCOLOGY-GROUP | CISPLATIN | ONCOLOGY | DENSE CHEMOTHERAPY | HIGH-DOSE CHEMOTHERAPY | COMPLETE-RESPONSE | CANCER | Testicular Neoplasms - mortality | Prognosis | Follow-Up Studies | Peritoneal Neoplasms - blood | Humans | Middle Aged | Male | Mediastinal Neoplasms - mortality | Neoplasms, Germ Cell and Embryonal - blood | Testicular Neoplasms - pathology | Cisplatin - administration & dosage | Young Adult | Mediastinal Neoplasms - drug therapy | Neoplasm Metastasis | Organoplatinum Compounds - administration & dosage | Peritoneal Neoplasms - drug therapy | Chorionic Gonadotropin - blood | Adult | Female | Neoplasms, Germ Cell and Embryonal - drug therapy | Paclitaxel - administration & dosage | Precision Medicine | alpha-Fetoproteins - metabolism | Peritoneal Neoplasms - pathology | Mediastinal Neoplasms - blood | Neoplasms, Germ Cell and Embryonal - mortality | Etoposide - administration & dosage | Survival Rate | Bleomycin - administration & dosage | Peritoneal Neoplasms - mortality | Recombinant Proteins - administration & dosage | Biomarkers, Tumor - blood | Ifosfamide - administration & dosage | International Agencies | Testicular Neoplasms - drug therapy | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Mediastinal Neoplasms - pathology | Adolescent | Aged | Neoplasm Staging | Testicular Neoplasms - blood | Neoplasms, Germ Cell and Embryonal - pathology | Granulocyte Colony-Stimulating Factor - administration & dosage | Chemotherapy | Tumors | Cancer | Analysis | Index Medicus
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 11/2009, Volume 27, Issue 33, pp. 5601 - 5606
Journal Article
British Journal of Cancer, ISSN 0007-0920, 03/2016, Volume 114, Issue 7, pp. 737 - 743
Journal Article
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 01/2018, Volume 378, Issue 3, pp. 230 - 240
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2014, Volume 15, Issue 11, pp. 1207 - 1214
Summary Background Olaparib is a poly(ADP-ribose) polymerase inhibitor and cediranib is an anti-angiogenic agent with activity against VEGF receptor (VEGFR) 1,... 
Hematology, Oncology and Palliative Medicine | TRIAL | POLY(ADP-RIBOSE) POLYMERASE | ONCOLOGY | BEVACIZUMAB | DOWN-REGULATION | FALLOPIAN-TUBE | OPEN-LABEL | EPITHELIAL OVARIAN | MAINTENANCE THERAPY | PRIMARY PERITONEAL | NEGATIVE BREAST-CANCER | Piperazines - administration & dosage | Confidence Intervals | Follow-Up Studies | Humans | Middle Aged | Ovarian Neoplasms - pathology | Neoplasm Recurrence, Local - drug therapy | Ovarian Neoplasms - mortality | Neoplasm Recurrence, Local - mortality | Cisplatin - administration & dosage | Dose-Response Relationship, Drug | Neoplasm Recurrence, Local - pathology | Neoplasms, Glandular and Epithelial - mortality | Aged, 80 and over | Adult | Female | Quinazolines - administration & dosage | Ovarian Neoplasms - drug therapy | Neoplasms, Glandular and Epithelial - pathology | Phthalazines - administration & dosage | Drug Administration Schedule | Risk Assessment | Kaplan-Meier Estimate | Treatment Outcome | Disease-Free Survival | Maximum Tolerated Dose | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Neoplasms, Glandular and Epithelial - drug therapy | Survival Analysis | Carcinoma, Ovarian Epithelial | Aged | Women | Antimitotic agents | Relapse | Oncology, Experimental | Research | Antineoplastic agents | Vascular endothelial growth factor | Sugars | Cancer | Diseases | Monosaccharides | Ovarian cancer | Index Medicus
Journal Article